Feilan Wang

798 total citations
18 papers, 646 citations indexed

About

Feilan Wang is a scholar working on Molecular Biology, Economics and Econometrics and Oncology. According to data from OpenAlex, Feilan Wang has authored 18 papers receiving a total of 646 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Economics and Econometrics and 4 papers in Oncology. Recurrent topics in Feilan Wang's work include Energy, Environment, Economic Growth (5 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Immune Response and Inflammation (2 papers). Feilan Wang is often cited by papers focused on Energy, Environment, Economic Growth (5 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Immune Response and Inflammation (2 papers). Feilan Wang collaborates with scholars based in China, Philippines and United States. Feilan Wang's co-authors include Lidia Averboukh, Zhen Guo, Peng Liang, Weimin Zhu, Xiaoying Zhang, Mark Nuttall, Jianfeng Li, Zeyun Li, David J. Rickard and Sanjay Kumar and has published in prestigious journals such as Nucleic Acids Research, Blood and Cancer Research.

In The Last Decade

Feilan Wang

17 papers receiving 625 citations

Peers

Feilan Wang
Feilan Wang
Citations per year, relative to Feilan Wang Feilan Wang (= 1×) peers Mangmang Li

Countries citing papers authored by Feilan Wang

Since Specialization
Citations

This map shows the geographic impact of Feilan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feilan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feilan Wang more than expected).

Fields of papers citing papers by Feilan Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feilan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feilan Wang. The network helps show where Feilan Wang may publish in the future.

Co-authorship network of co-authors of Feilan Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Feilan Wang. A scholar is included among the top collaborators of Feilan Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feilan Wang. Feilan Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Li, Jianfeng, et al.. (2023). Performance Simulation of Permeable Concrete Materials Combined with Nanotechnology in Rainwater Management. Processes. 11(3). 768–768. 2 indexed citations
3.
Wang, Feilan, Wing‐Keung Wong, Geovanny Genaro Reiván Ortiz, et al.. (2023). Economic analysis of sustainable exports value addition through natural resource management and artificial intelligence. Resources Policy. 82. 103541–103541. 12 indexed citations
5.
Wang, Feilan, et al.. (2023). The interplay of Fintech, natural resources, globalization, and environmental sustainability in China: A BARDL investigation. Resources Policy. 88. 104476–104476. 11 indexed citations
6.
Wang, Feilan, et al.. (2022). Profound Impact of Economic Openness and Digital Economy towards a Sustainable Development: A New Look at RCEP Economies. Sustainability. 14(21). 13922–13922. 9 indexed citations
7.
Li, Jianfeng, et al.. (2022). Application of visualization modeling technology in the determination of reinforcement range of deep soft soil foundation. Environmental Earth Sciences. 81(7). 2 indexed citations
8.
Wang, Yuguang, et al.. (2019). Abstract LB-018: Orally active small molecule PD-L1 inhibitor demonstrating similar efficacy as Durvalumab in human knock-in MC38 model. Cancer Research. 79(13_Supplement). LB–18. 2 indexed citations
10.
Wang, Yuguang, He Zhou, Nong Zhang, et al.. (2018). Abstract 3851: Novel small-molecule inhibitor of PD1/PDL1 pathway demonstrated single agent and drug combo effectiveness in cancer immunotherapy. Cancer Research. 78(13_Supplement). 3851–3851. 4 indexed citations
11.
Wang, Yuguang, et al.. (2018). Preclinical Evaluation of MAX-40279, a FLT3/FGFR Dual Kinase Inhibitor for Treatment of Acute Myeloid Leukemia. Blood. 132(Supplement 1). 3997–3997. 4 indexed citations
12.
Kirkpatrick, Robert B., Michael Grooms, Feilan Wang, et al.. (2006). Bacterial production of biologically active canine interleukin-1β by seamless SUMO tagging and removal. Protein Expression and Purification. 50(1). 102–110. 10 indexed citations
13.
14.
Nuttall, Mark, Daniel P. Nadeau, Paul W. Fisher, et al.. (2000). Inhibition of caspase‐3‐like activity prevents apoptosis while retaining functionality of human chondrocytes in vitro. Journal of Orthopaedic Research®. 18(3). 356–363. 79 indexed citations
15.
Nuttall, Mark, John C. Lee, Paul R. Murdock, et al.. (1999). Amphibian Melanophore Technology as a Functional Screen for Antagonists of G-Protein Coupled 7-Transmembrane Receptors. SLAS DISCOVERY. 4(5). 269–277. 4 indexed citations
16.
Biswas, Debajit K., Lidia Averboukh, Shijie Sheng, et al.. (1998). Classification of Breast Cancer Cells on the Basis of a Functional Assay for Estrogen Receptor. Molecular Medicine. 4(7). 454–467. 21 indexed citations
17.
Liang, Peng, Weimin Zhu, Xiaoying Zhang, et al.. (1994). Differential display using one-base anchored oligo-dT primers. Nucleic Acids Research. 22(25). 5763–5764. 287 indexed citations
18.
Wang, Feilan, et al.. (1991). Purification and Characterization of the polygalacturo nase from Tomato Fruits. Journal of Integrative Plant Biology. 33(3).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026